CBD Related Content

CBD oil may help alleviate sleeping problems experienced as research reveals over 52% of Brits cite temperature as the main factor keeping them from getting enough sleep.

Snoring? Dry skin? Sleeplessness? Eczema? Inflammation? Studies continue to explore the benefits of CBD oil, the cannabis plant extract.

Mile High Labs has announced support for the findings in a Centre for Medicinal Cannabis report.

Here we provide a brief introduction to the medical benefits of CBD and medical Cannabis, with an overview of treatments that have been implemented.

Research reveals Londoners are the most anxious and have the worst work-life balance in the UK and many would choose to use CBD oil rather than seeing their GP.

A five-year license has been issued to two companies allowing the cultivation and processing of medical cannabis products.

King's College London researchers found that cannabidiol (CBD) could hold promise as a treatment for psychosis, according to reasonable benefits seen in a clinical trial.

From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.

Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.

Dennis R. Carty, Ph.D. and Pamela J. Lein, Ph.D., University of California, highlight the rising trend of marijuana use during pregnancy and the implications surrounding it.

Dr Mark Ware, Chief Medical Officer at Canopy Growth, provides an overview of the research that already exists around medicinal cannabis and explains why there is a need to educate clinicians further.

European Cannabis Holdings (ECH) has announced plans to open The Medical Cannabis Clinics in a step toward aiding patients living with a range of chronic conditions.

A survey by Rehab 4 Addiction using Facebook reveals more than 80% of people aged 55+ are contemplating asking their doctor about medicinal cannabis following the upcoming the change that’s due to kick in next week

Home secretary, Sajid Javid has announced that medicinal products that derive from cannabis will be made available on prescription by Autumn.

David Bearman, M.D., Executive VP of the American Academy of Cannabinoid Medicine details the research priorities for cannabis, one of the most thoroughly studied plants of all time 

Bradley Moore, CEO of GCAC discusses how artificial intelligence and blockchain (trusted data) solve the paradox of limited medical cannabis data and anecdotal user information

Writer, medical cannabis patient, a grower and budtender for GrassRoots Medicinal in Squamish, Caleb McMillan, provides his thoughts on cannabis developments in North America today

Board Member for Canadians for Fair Access to Medical Marijuana (CFAMM), Peter Thurley, shares his views on medical cannabis advocacy and education issues

Rising blockchain technology could be a game changer for legal marijuana, according to small-cap cannabis stock Emerald Health Therapeutics